Empfehlungen zum Telemonitoring bei Patienten mit implantierten Herzschrittmachern, Defibrillatoren und kardialen Resynchronisationssystemen

Dubner S, Auricchio A, Steinberg JS et al (2012) ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs). Europace 14:278–293

Wilkoff BL, Auricchio A, Brugada J et al (2008) HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations. Europace 10:707–725

Heidbuchel H (2011) Telemonitoring of implantable cardiac devices: hurdles towards personalised medicine. Heart 97:931–939

Platt S, Furman S, Gross JN et al (1996) Transtelephone monitoring for pacemaker follow-up 1981–1994. Pacing Clin Electrophysiol 19:2089–2098

Fetter JG, Stanton MS, Benditt DG et al (1995) Transtelephonic monitoring and transmission of stored arrhythmia detection and therapy data from an implantable cardioverter defibrillator. Pacing Clin Electrophysiol 8:1531–1539

Lazarus A (2007) Remote, wireless, ambulatory monitoring of implantable pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy systems: analysis of a worldwide database. Pace 30:S2–S12

Spencker S, Mueller D, Marek A et al (2007) Severe pacemaker lead perforation detected by an automatic homemonitoring system. Eur Heart J 28:1432

Neuzil P, Taborsky M, Holy F et al (2008) Early automatic remote detection of combined lead insulation defect and ICD damage. Europace 10:556–557

Guedon-Moreau L, Chevalier P, Marquie C et al (2010) Contributions of remote monitoring to the follow-up of implantable cardioverter-defibrillator leads under advisory. Eur Heart J 31:2246–2252

Varma N, Michalski J, Epstein AE et al (2010) Automatic remote monitoring of cardioverter-defibrillator lead and generator performance: the Lumos-T safely reduseS routine office device follow-up (TRUST) trial. Circ Arrhythm Electrophysiol 3:428–436

Halimi F, Clementy J, Attuel P et al (2008) Optimized post-operative surveillance of permanent pacemakers by home monitoring: the OEDIPE trial. Europace 10:1392–1399

Isreal CW, Bänsch D, Böcker D et al (2012) Empfehlungen der Deutschen Gesellschaft für Kardiologie (Arbeitsgruppe Rhythmologie) zum Umgang mit Patienten mit ICD-Elektroden Riata und Riata ST der Firma St. Jude Medical.Herzschr Elektrophys 23:107–115

Varma N, Epstein AE, Irimpen A et al (2010) Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up -The Lumos-T safely reduces routine office device follow-up (TRUST) trial. Circulation 122:325–332

Ricci RP, Morichelli L, Santini M (2009) Remote control of implanted devices through Home Monitoring technology improves detection and clinical management of atrial fibrillation. Europace 11:54–61

Crossley GH, Boyle A, Vitense H et al (2011) The CONNECT clinical evaluation of remote notification to reduce time to clinical decision trial: the value of wireless remote monitoring with automatic clinician alerts. J Am Coll Cardiol 57:1181–1189

Ip J, Wald AL, Lip GYH et al (2009) Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: rationale, design, and clinical characteristics of the initially enrolled cohort: the IMPACT study. Am Heart J 158:364–370

Perings C, Bauer WR, Bondke HJ et al (2011) Remote monitoring of implantable-cardioverter defibrillators: results from the Reliability of IEGM Online Interpretation (RIONI) study. Europace 13:221–229

http://www.clinicaltrials.gov/ct2/show/NCT00598026?term=EVATEL&rank=l

http://www.clinicaltrials.gov/ct2/show/NCT00989417?term=ECOST&rank=l

Saxon LA, Hayes DL, Roosevelt Gilliam F et al (2010) Long-term outcome after ICD and CRT implantation and influence of remote device follow-up – the ALTITUDE Survival Study. Circulation 122:2359–2367

Landolina M, Perego GB, Lunati M et al (2012) Remote monitoring reduces healthcare use and improves qualitiy of care in heart failure patients with implantable defibrillators. Circulation 125:2985–2992

Mabo P, Victor F, Bazin P et al (2012) A randomized trial of long-term remote monitoring of pacemaker recipients (The COMPAS trial). Eur Heart J 33:1105–1111

Koplan BA, Kaplan AJ, Weiner S et al (2009) Heart failure decompensation and allcause mortality in relation to biventricular pacing in patients with heart failure: is a goal of 100 % biventricular pacing necessary? J Am Coll Cardiol 53:355–360

Saxon LA, Boehmer JP, Neumann S et al (2007) Remote active monitoring in patients with heart failure (RAPID-RF): design and rationale. J Cardiac Fail 13:241–246

Conraads VM, Tavazzi L, Santini M et al (2011) Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF-trial. Eur Heart J 32:2266–2273

Van Veldhuisen DJ, Braunschweig F, Conraads VM et al (2011) Intrathoracic impedance, audible patient alerts and outcome in patients with heart failure. Circulation 124:1697–1699

Fonarow GC, Abraham WT, Albert NM et al (2008) Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF. Arch Intern Med 168:847–854

Adamson PB, Smith AL, Abraham WT (2004) Countinous automatic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device. Circulation 110:2389–2394

Boveda SME, Jacob S, Defaye P et al (2009) Incidence and prognostic significance of sustained ventricular tachycardias in heart failure patients implanted with biventricular pacemakers without a back-up defibrillator: results from the prospective, multicentre Mona Lisa cohort study. Eur Heart J 30:1237–1244

Sack S, Wende CM, Nägele H et al (2011) Potential value of automated daily screening of cardiac resynchronization therapy defibrillator diagnostics for prediction of major cardiovascular events: results from Home-CARE (Home Monitoring in Cardiac Resynchronization Therapy) study. Eur J Heart Fail 13:1019–1027

Whellan DJ, Ousdigian KT, Al-Khabtib SM et al (2010) Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hosptializations. J Am Coll Cardiol 55:1803–1810

Burri H, Quesada A, Ricci RP et al (2010) The monitoring resynchronization devices and cardiac patients (MORE-CARE) study: rationale and design. Am Heart J 160:42–48

Heidbuchel H, Lioen P, Foulon S et al (2008) Potential role of remote for scheduled and unscheduled evaluations of patients with an implantable defibrillator. Europace 10:351–357

Hindricks G, Bauer WR, Schwab JO et al (2008) Was bringt die Telekardiologie für Arzt und Patient? Dtsch Ärztebl 105:B141–B144

Hansen C, Rybak K (2008) Medtronic CareLink network registry, presentation of interim analysis. Meeting of German Society of Cardiology

Ricci R, dÓnofrio A, Padeletti L et al (2012) Rationale and design of the health economics evaluation registry for remote follow-up: TARIFF. Europace 14:1661–1665

Varma N, Ricci RR (2013) Telemedicine and cardiac implants: what is the benefit? Eur Heart J 34

Brachmann J, Böhm M, Rybak K et al (2011) Fluid status monitoring with a wireless network to reduce cardiovascular-related hospitalizations and mortality in heart failure: rationale and design of the OptiLink HF Study (Optimization of Heart Failure Management using OptiVol Fluid Status Monitoring and CareLink). Eur J Heart Fail 13:796–804